| |
 |
|
Class Information
Number: 424/184.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.)
Description: Subject matter involving an antigen, an epitope, or another immunospecific immunoeffector, such as an immunospecific vaccine, an immunospecific stimulator of cell-mediated immunity, an immunospecific tolerogen, or an immunospecific immunosuppressor.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/275.1 |
Allergen or component thereof (e.g., ragweed pollen, etc.) |
192 |
| 424/185.1 |
Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same |
1,763 |
| 424/234.1 |
Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) |
1,021 |
| 424/277.1 |
Cancer cell or component thereof |
382 |
| 424/203.1 |
Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) |
207 |
| 424/202.1 |
Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) |
203 |
| 424/201.1 |
Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) |
133 |
| 424/193.1 |
Conjugate or complex |
840 |
| 424/274.1 |
Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., trichophyton, etc.) |
96 |
| 424/192.1 |
Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) |
953 |
| 424/198.1 |
Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof |
463 |
| 424/265.1 |
Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) |
246 |
| 424/200.1 |
Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof |
244 |
| 424/199.1 |
Recombinant virus encoding one or more heterologous proteins or fragments thereof |
580 |
| 424/204.1 |
Virus or component thereof |
988 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7371534 |
Sensitive intracellular calcium assay |
May. 13, 2008 |
| 7371394 |
Antigenic composition of a Pseudomonas aeruginosa protein |
May. 13, 2008 |
| 7371393 |
Methods for reducing fecal shedding |
May. 13, 2008 |
| 7371392 |
Cd40 ligand adjuvant for respiratory syncytial virus |
May. 13, 2008 |
| 7371386 |
Conserved motif of hepatitis C virus E2/NS1 region |
May. 13, 2008 |
| 7371385 |
Method of treating immune pathologies with low dose estrogen |
May. 13, 2008 |
| 7368565 |
Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
May. 6, 2008 |
| 7368136 |
Preventives or remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters |
May. 6, 2008 |
| 7368107 |
Tumor antigen peptides derived from cyclophilin B |
May. 6, 2008 |
| 7364893 |
Recombinant infectious laryngotracheitis virus and uses thereof |
Apr. 29, 2008 |
| 7364744 |
Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV |
Apr. 29, 2008 |
| 7364743 |
Nucleotide sequence encoding PTD and CEA fusion protein, TAT-CEA fusion protein, anti-tumor vaccine and pharmaceutical composition for treating tumor comprising the fusion protein |
Apr. 29, 2008 |
| 7364741 |
Peptides of human Papilloma virus for use in human T cell response inducing compositions |
Apr. 29, 2008 |
| 7364740 |
Molecular differences between species of the M. tuberculosis complex |
Apr. 29, 2008 |
| 7364739 |
Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of Haemophilus influenzae infections |
Apr. 29, 2008 |
| 7364729 |
Method of inducing a CTL response |
Apr. 29, 2008 |
| 7361359 |
Neospora caninum isolate |
Apr. 22, 2008 |
| 7361356 |
Self-assembling recombinant papillomavirus capsid proteins |
Apr. 22, 2008 |
| 7361352 |
Influenza immunogen and vaccine |
Apr. 22, 2008 |
| 7361348 |
Immunogenic glycopeptides, screening, preparation and uses |
Apr. 22, 2008 |
| 7358340 |
PRO19563 antibodies |
Apr. 15, 2008 |
| 7358234 |
Induction of a protective immune response through microprojectiles coated with a DNA sequence encoding an immunogenic protein |
Apr. 15, 2008 |
| 7357936 |
Adjuvant systems and vaccines |
Apr. 15, 2008 |
| 7357931 |
Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
Apr. 15, 2008 |
| 7355012 |
Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells |
Apr. 8, 2008 |
| 7355011 |
Biological products |
Apr. 8, 2008 |
| 7354588 |
Functional derivatives of ICAM-1 with altered ability to bind LFA-1 or HRV |
Apr. 8, 2008 |
| 7354587 |
Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
Apr. 8, 2008 |
| 7351795 |
PRO19563 polypeptides |
Apr. 1, 2008 |
| 7351435 |
Deglycosylated ricin toxin a-chain vaccine |
Apr. 1, 2008 |
| 7351415 |
Adenovirus formulations |
Apr. 1, 2008 |
| 7351413 |
Stabilized HBc chimer particles as immunogens for chronic hepatitis |
Apr. 1, 2008 |
| 7348136 |
Method and device for detecting feline immunodeficiency virus |
Mar. 25, 2008 |
| 7348008 |
Ricin-like toxins for treatment of cancer |
Mar. 25, 2008 |
| 7348007 |
Mage C2 antigenic peptides and uses thereof |
Mar. 25, 2008 |
| 7348006 |
Vaccines comprising aluminium adjuvants and histidine |
Mar. 25, 2008 |
| 7348005 |
Oral tolerance induction by collagen to prevent allograft rejection |
Mar. 25, 2008 |
| 7345018 |
Method of treating side effects induced by therapeutic agents |
Mar. 18, 2008 |
| 7344842 |
Prion test |
Mar. 18, 2008 |
| 7344720 |
Vaccine composition |
Mar. 18, 2008 |
| 7344719 |
Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
Mar. 18, 2008 |
| 7344718 |
Yersinia species compositions |
Mar. 18, 2008 |
| 7344717 |
Use of erythropoietin in the treatment of rheumatoid arthritis |
Mar. 18, 2008 |
| 7342101 |
Compositions and methods comprising a protective antigen of Coccidiodes immitis |
Mar. 11, 2008 |
| 7341732 |
Methods for treating mastitis in a milk producing animal |
Mar. 11, 2008 |
| 7341726 |
Modified HCV peptide immunogens |
Mar. 11, 2008 |
| 7341723 |
Nucleic acid construct encoding a processing component derived from the N-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide |
Mar. 11, 2008 |
| 7339043 |
Compositions and methods for affecting virulence determinants in bacteria |
Mar. 4, 2008 |
| 7335736 |
Compositions and methods for detecting Treponema palidum |
Feb. 26, 2008 |
| 7335733 |
Tissue cement proteins from Rhipicephalus appendiculatus |
Feb. 26, 2008 |
|
|
|
